Aberrant IL-4 production by SOCS3-over-expressing T cells during infection with Leishmania major exacerbates disease manifestations

International Immunology

Volumn 23, Issue 3, 2011, Pages 195-202

  Nakaya, Mako ^a,b   Hamano, Shinjiro ^c   Kawasumi, Miyuri ^d   Yoshida, Hiroki ^b   Yoshimura, Akihiko ^a,d,e   Kobayashi, Takashi ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cytokine; Regulatory T cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; GENE OVEREXPRESSION; IN VITRO STUDY; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE CLEARANCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

EID: 79952577834     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq472     Document Type: Article

References (33)

1. Sacks, D. and Noben-Trauth, N. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845.
2. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
3. Reiner, S. L. and Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
4. Belosevic, M., Finbloom, D. S., Van Der Meide, P. H., Slayter, M. V. and Nacy, C. A. 1989. Administration of monoclonal anti-IFNgamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266.
5. Heinzel, F. P., Rerko, R. M., Ahmed, F. and Pearlman, E. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
6. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S. and Locksley, R. M. 1990. Cure of murine leishmaniasis with antiinterleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115.
7. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
8. Mangan, P. R., Harrington, L. E., O'Quinn, D. B. et al. 2006. Transforming growth factor-beta induces development of the Th17 lineage. Nature 441:231.
9. Chen, W., Jin, W., Hardegen, N. et al. 2003. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875.
10. Xu, D., Liu, H., Komai-Koma, M. et al. 2003. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170:394.
11. Yoshimura, A., Naka, T. and Kubo, M. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454.
12. Yasukawa, H., Ohishi, M., Mori, H. et al. 2003. IL-6 induces an antiinflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:551.
13. Kinjyo, I., Inoue, H., Hamano, S. et al. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203:1021.
14. Bogdan, C., Rollinghoff, M. and Diefenbach, A. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64.
15. Seki, Y., Inoue, H., Nagata, N. et al. 2003. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nat. Med. 9:1047.
16. Chatelain, R., Varkila, K. and Coffman, R. L. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
17. Barral-Netto, M., Barral, A., Brownell, C. E. et al. 1992. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257:545.
18. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. and Sacks, D. L. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502.
19. Groux, H., Cottrez, F., Rouleau, M. et al. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigenpresenting cells. J. Immunol. 162:1723.
20. Powrie, F., Correa-Oliveira, R., Mauze, S. and Coffman, R. L. 1994. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ Tcells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
21. Himmelrich, H., Launois, P., Maillard, I. et al. 2000. BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164:4819.
22. Julia, V., Rassoulzadegan, M. and Glaichenhaus, N. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421.
23. Launois, P., Maillard, I., Pingel, S. et al. 1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541.
24. Erb, K. J., Blank, C. and Moll, H. 1996. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response. Immunol. Cell Biol. 74:239.
25. Yamamoto, K., Yamaguchi, M., Miyasaka, N. and Miura, O. 2003. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. Biochem. Biophys. Res. Commun. 310:1188.
26. Hondowicz, B. D., Park, A. Y., Elloso, M. M. and Scott, P. 2000. Maintenance of IL-12-responsive CD4+ Tcells during a Th2 response in Leishmania major-infected mice. Eur. J. Immunol. 30:2007.
27. Nishikomori, R., Gurunathan, S., Nishikomori, K. and Strober, W. 2001. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling. J. Immunol. 166:6776.
28. Launois, P., Swihart, K. G., Milon, G. and Louis, J. A. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317.
29. Reiner, S. L., Zheng, S.,Wang, Z. E., Stowring, L. and Locksley, R.M. 1994. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179:447.
30. Hunter, C. A., Villarino, A., Artis, D. and Scott, P. 2004. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol. Rev. 202:106.
31. Yoshimoto, T., Yoshimoto, T., Yasuda, K., Mizuguchi, J. and Nakanishi, K. 2007. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 179:4415.
32. Yoshida, H., Hamano, S., Senaldi, G. et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569.
33. Huber, M., Timms, E., Mak, T. W., Röllinghoff, M. and Lohoff, M. 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun. 66:3968.